These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7816338)
1. Different modifications of the dopamine metabolism in the core and shell parts of the nucleus accumbens following CCK-A receptor stimulation in the shell region. Ladurelle N; Durieux C; Roques BP; Daugé V Neurosci Lett; 1994 Aug; 178(1):5-10. PubMed ID: 7816338 [TBL] [Abstract][Full Text] [Related]
2. Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats. Ladurelle N; Keller G; Roques BP; Daugé V Brain Res; 1993 Nov; 628(1-2):254-62. PubMed ID: 8313154 [TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry. Reum T; Schäfer U; Marsden CA; Fink H; Morgenstern R Neuropeptides; 1997 Feb; 31(1):82-8. PubMed ID: 9574843 [TBL] [Abstract][Full Text] [Related]
4. The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens. Ladurelle N; Roques BP; Daugé V J Neurosci; 1995 Apr; 15(4):3118-27. PubMed ID: 7722650 [TBL] [Abstract][Full Text] [Related]
5. Regional amines levels in the rat brain following intra-accumbens cholecystokinin and intraperitoneal amphetamine pre-treatment. Heidbreder C; Gewiss M; De Potter W; De Witte P Arch Int Physiol Biochim Biophys; 1992; 100(3):267-73. PubMed ID: 1382678 [TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor. Pu SF; Zhuang HX; Han JS Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614 [TBL] [Abstract][Full Text] [Related]
7. CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens. Daugé V; Steimes P; Derrien M; Beau N; Roques BP; Féger J Pharmacol Biochem Behav; 1989 Sep; 34(1):157-63. PubMed ID: 2626446 [TBL] [Abstract][Full Text] [Related]
8. Systemic administration of CCK-8S, but not CCK-4, enhances dopamine turnover in the posterior nucleus accumbens: a microdialysis study in freely moving rats. Kariya K; Tanaka J; Nomura M Brain Res; 1994 Sep; 657(1-2):1-6. PubMed ID: 7820607 [TBL] [Abstract][Full Text] [Related]
9. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens. Laitinen K; Crawley JN; Mefford IN; De Witte P Brain Res; 1990 Jul; 523(2):342-6. PubMed ID: 1698106 [TBL] [Abstract][Full Text] [Related]
10. Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT1B agonist into the dorsal subiculum: implications for schizophrenia. Boulenguez P; Peters SL; Mitchell SN; Chauveau J; Gray JA; Joseph MH J Psychopharmacol; 1998; 12(3):258-67. PubMed ID: 10958252 [TBL] [Abstract][Full Text] [Related]
11. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats. Ladurelle N; Keller G; Blommaert A; Roques BP; Daugé V Eur J Neurosci; 1997 Sep; 9(9):1804-14. PubMed ID: 9383203 [TBL] [Abstract][Full Text] [Related]
12. Involvement of D2 dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus accumbens. Derrien M; Durieux C; Daugé V; Roques BP Brain Res; 1993 Jul; 617(2):181-8. PubMed ID: 8402145 [TBL] [Abstract][Full Text] [Related]
13. Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites. Léna I; Roques BP; Durieux C J Neurochem; 1997 Jan; 68(1):162-8. PubMed ID: 8978722 [TBL] [Abstract][Full Text] [Related]
14. [The effect of cholecystokinin octapeptide on ethanol-induced changes in motor activity and in dopamine metabolism in the nucleus accumbens of the rat brain]. Medvedeva OF; Sudakova SK; Anokhina IP; Kianmaa K Eksp Klin Farmakol; 1996; 59(6):44-7. PubMed ID: 9181874 [TBL] [Abstract][Full Text] [Related]
15. CCK/dopamine interactions in Fawn-Hooded and Wistar-Kyoto rat brain. Lodge DJ; Short JL; Mercer LD; Beart PM; Lawrence AJ Peptides; 2000 Mar; 21(3):379-86. PubMed ID: 10793220 [TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. Marshall FH; Barnes S; Hughes J; Woodruff GN; Hunter JC J Neurochem; 1991 Mar; 56(3):917-22. PubMed ID: 1993898 [TBL] [Abstract][Full Text] [Related]
17. Individual differences in the feeding response to CCKB antagonists: role of the nucleus accumbens. Sills TL; Vaccarino FJ Peptides; 1996; 17(4):593-9. PubMed ID: 8804067 [TBL] [Abstract][Full Text] [Related]
18. Effects of systemically administered ceruletide on the in vivo release and metabolism of dopamine in the medial prefrontal cortex of awake, freely moving rats: an in vivo microdialysis study. Hagino Y; Moroji T Brain Res; 1994 Apr; 644(1):40-6. PubMed ID: 8032948 [TBL] [Abstract][Full Text] [Related]
19. Involvement of D2 dopamine receptors in the opposing effects of two CCK-B agonists in a spatial recognition memory task: role of the anterior nucleus accumbens. Léna I; Dh tel H; Garbay C; Daugé V Psychopharmacology (Berl); 2001 Jan; 153(2):170-9. PubMed ID: 11205416 [TBL] [Abstract][Full Text] [Related]
20. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro. Marshall FH; Barnes S; Pinnock RD; Hughes J Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]